• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Board Meeting, 09-02-2026: Outcome of Board Meeting

    09-02-2026 | 01:20 pm

    Zydus Lifesciences' board approved its Q3 & 9M consolidated results. Q3 revenue stood at ₹6,864.5 Cr, with net profit at ₹1,042.1 Cr. 9M revenue reached ₹19,561.4 Cr, and net profit was ₹3,767.5 Cr. Performance includes recent strategic acquisitions.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited